Recordati

Pharmaceuticals

REC.MI

€ 44 (0.52)%

Share price

$ 10 bn

Market Cap

$ 12 bn

Enterprise Value

Carbon footprint

GHG emissions per $ 1 mln investment

0.1x the weighted average for S&P 500

FY2021

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Recordati reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 43 Kt (+0.47/+1.1% y-o-y). At the sime time, carbon intensity was down at 23 t (-2.1 /-8.4% y-o-y).

No public disclosure of Scope 3 emissions has been found for Recordati at the moment.

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Date	Total CO2e emissions (market-based Scope 1 & 2) (Kt)	Scope 1	Scope 2	Revenue (USDm)	Carbon intensity (tons of CO2e) / (USDm)
2021Q4	43	38	5.4	1,875	23
2020Q4	42	37	5.8	1,697	25
2019Q4	45	37	8.2	1,665	27
2018Q4	49	35	13	1,599	30
2017Q4	47	34	12	1,454	32

Recordati

Carbon footprint

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Recordati's carbon footprint

Company environmental metrics